Compare ATAT & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATAT | STVN |
|---|---|---|
| Founded | 2013 | 1949 |
| Country | China | Italy |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Containers/Packaging |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 3.7B |
| IPO Year | 2021 | 2021 |
| Metric | ATAT | STVN |
|---|---|---|
| Price | $32.01 | $17.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $49.00 | $25.67 |
| AVG Volume (30 Days) | ★ 874.2K | 364.2K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.06% | 0.39% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $25.48 | $9.67 |
| Revenue Next Year | $18.11 | $9.99 |
| P/E Ratio | ★ $26.11 | $27.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $31.14 | $12.89 |
| 52 Week High | $43.17 | $28.00 |
| Indicator | ATAT | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 38.96 | 50.76 |
| Support Level | N/A | $16.75 |
| Resistance Level | $38.93 | $19.41 |
| Average True Range (ATR) | 1.13 | 0.96 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 25.85 | 51.78 |
Atour Lifestyle Holdings Ltd is an upper-midscale hotel chain in China. The company derives revenues from franchise and management fees from its manachised hotels and sales of hotel supplies to manachised hotels, Operations of leased hotels, and sales of retail products. The company has one operating segment, which is the Atour Group.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.